title: Optimising the lymphoma response criteria in the era of targeted therapy.
authors.affiliation: Department of Lymphoma and Myeloma, University of Texas MD Anderson Cancer Center, Houston, USA. ayounes@mdanderson.org
authors.forename: Anas
authors.initials: A
authors.lastname: Younes
authors.forename: Anton
authors.initials: A
authors.lastname: Hagenbeek
authors.forename: Bertrand
authors.initials: B
authors.lastname: Coiffier
mesh_terms: D000970:Antineoplastic Agents / Q000627:therapeutic use*; D003937:Diagnosis, Differential; D018572:Disease-Free Survival; D016503:Drug Delivery Systems; D005188:False Negative Reactions; D005189:False Positive Reactions; D006801:Humans; D008223:Lymphoma / Q000188:drug therapy*; D049268:Positron-Emission Tomography
chemical_list: D000970:Antineoplastic Agents